 |
Recombinant humanized monoclonal antibody directed against an epidermal growth factor receptor |
|---|---|
| Trade Name | |
| Orphan Indication | Glioblastoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-02-17 00:00:00 |
| Sponsor | AbbVie, Inc.;1 N. Waukegan Road;North Chicago, Illinois, 60064 |
